Warfarin therapy for giant aneurysm prevents myocardial infarction in Kawasaki disease

Pediatric Cardiology

Volumn 29, Issue 2, 2008, Pages 398-401

  Sugahara, Yoko ^a   Ishii, Masahiro ^b   Muta, Hiromi ^a   Iemura, Motofumi ^a   Matsuishi, Toyojiro ^a   Kato, Hirohisa ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

Giant aneurysm; Kawasaki disease; Myocardial infarction; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRIDAMOLE; TICLOPIDINE; WARFARIN;

ADOLESCENT; ANEURYSM; ANGIOCARDIOGRAPHY; ARTICLE; BRAIN HEMORRHAGE; CHILD; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEALTH HAZARD; HEART INFARCTION; HUMAN; INCIDENCE; INFANT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; TREATMENT OUTCOME;

ADOLESCENT; ANTICOAGULANTS; CHILD; CHILD, PRESCHOOL; CORONARY ANEURYSM; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; WARFARIN;

EID: 40949123534     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-007-9132-9     Document Type: Article

References (5)

1. Andrew M, Marzinotto V, Brooker L, Adams M, Ginsberg J, Freedom R, Williams W (1994) Oral anticoagulation therapy in pediatric patients: a prospective study. Thromb Haemost 71:265-269
2. Kato H, Ichinose E, Yoshioka F, Takechi T, Matsunaga S, Suzuki K, Rikitake N (1982) Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study. Am J Cardiol 49:1758-1766
3. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R (1996) Long-term consequences of Kawasaki disease: a 10 to 21 year follow-up study of 594 patients. Circulation 94:1379-1385
4. Newburger JW, Takahashi M, Gerber MA, et al. (2004) Diagnosis, treatment, and long-term management of Kawasaki disease. A statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Circulation 110:2747-2771
5. Onouchi Z, Hamaoka K, Sakata K, Ozawa S, Shiraishi I, Itoi T, Kiyosawa N (2005) Long-term changes in coronary artery aneurysms in patients with Kawasaki disease: comparison of therapeutic regimens. Circ J 69:265-272